-
2
-
-
0031752685
-
Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
-
King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-1431
-
(1998)
Diabetes Care
, vol.21
, pp. 1414-1431
-
-
King, H.1
Aubert, R.E.2
Herman, W.H.3
-
3
-
-
0034678764
-
A symposium: Combining sulfonylureas and other oral agents
-
Riddle M. A symposium: combining sulfonylureas and other oral agents. Am J Med 2000;108(6A):15-22S
-
(2000)
Am J Med
, vol.108
, Issue.6 A
-
-
Riddle, M.1
-
4
-
-
67649342715
-
Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects
-
World Medical Association. Last amended with Note of Clarification on Paragraph 29 by the WMA General Assembly, Washington
-
World Medical Association. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. 52nd WMA General Assembly, Edinburgh, Scotland, October 2000. Last amended with Note of Clarification on Paragraph 29 by the WMA General Assembly, Washington 2002
-
(2002)
52nd WMA General Assembly, Edinburgh, Scotland, October 2000
-
-
-
5
-
-
0031851293
-
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
-
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553
-
(1998)
Diabet Med
, vol.15
, pp. 539-553
-
-
Alberti, K.G.1
Zimmet, P.Z.2
-
6
-
-
0030781339
-
Prevalence of diabetes and its risk factors in China, 1994
-
National Diabetes Prevention and Control Cooperative Group
-
Pan XR, Yang WY, Li GW, et al. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 1997;20:1664-1669
-
(1997)
Diabetes Care
, vol.20
, pp. 1664-1669
-
-
Pan, X.R.1
Yang, W.Y.2
Li, G.W.3
-
7
-
-
67649386275
-
-
DeFronzo RA, Ferrannini E, Keen H, et al., eds. Chicester, UK: John Wiley, Chapter 70
-
DeFronzo RA, Ferrannini E, Keen H, et al., eds. International Textbook of Diabetes Mellitus, 2nd edn, Chicester, UK: John Wiley, 2004:Chapter 70
-
(2004)
International Textbook of Diabetes Mellitus, 2nd Edn
-
-
-
8
-
-
0035374580
-
The prevalence of comorbid depression in adults with diabetes: A meta-analysis
-
Anderson Rj, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-1078 (Pubitemid 33716379)
-
(2001)
Diabetes Care
, vol.24
, Issue.6
, pp. 1069-1078
-
-
Anderson, R.J.1
Freedland, K.E.2
Clouse, R.E.3
Lustman, P.J.4
-
9
-
-
0038701750
-
The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy- naïve type 2 diabetes: A placebo-controlled, multicentre study
-
DOI 10.1023/A:1023495106160
-
Bech P, Moses R, Gomis R. The effect of prandial glucose regulation with repaglinide on treatment satisfaction, well-being and health status in patients with pharmacology-naïve type 2 diabetes: a placebo-controlled, multicentre study. Qual Life Res 2003;12:413-425 (Pubitemid 36609886)
-
(2003)
Quality of Life Research
, vol.12
, Issue.4
, pp. 413-425
-
-
Bech, P.1
Moses, R.2
Gomis, R.3
-
10
-
-
33847373590
-
Routine assessment of psychological well-being in people with diabetes - Validation of the WHO-5 Well-being Index in six countries
-
no 245
-
Shea S, Skovlund S, Bech P, et al. Routine assessment of psychological well-being in people with diabetes - validation of the WHO-5 Well-being Index in six countries. Diabetologia 2003;46(Suppl 2):A88[no 245]
-
(2003)
Diabetologia
, vol.46
, Issue.SUPPL. 2
-
-
Shea, S.1
Skovlund, S.2
Bech, P.3
-
11
-
-
33746426239
-
Health Care and patient-reported outcomes: Results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study
-
on behalf of the International DAWN Advisory Panel
-
Richard RR, Mark P, Linda MS; on behalf of the International DAWN Advisory Panel: Health Care and patient-reported outcomes: Results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabetes Care 2006;29:1249-1255
-
(2006)
Diabetes Care
, vol.29
, pp. 1249-1255
-
-
Richard, R.R.1
Mark, P.2
Linda, M.S.3
-
12
-
-
27944467231
-
The Diabetes, Attitudes, Wishes, and Needs (DAWN) Program: A new approach to improving outcomes of diabetes care
-
on behalf of the DAWN International Advisory Panel
-
Soren ES, Peyrot M; on behalf of the DAWN International Advisory Panel. The Diabetes, Attitudes, Wishes, and Needs (DAWN) Program: a new approach to improving outcomes of diabetes care. Diabetes Spectrum 2005;18:136-142
-
(2005)
Diabetes Spectrum
, vol.18
, pp. 136-142
-
-
Soren, E.S.1
Peyrot, M.2
-
13
-
-
0036059959
-
The DAWN (Diabetes Attitudes, Wishes and Needs) Study
-
Alberti G. The DAWN (Diabetes Attitudes, Wishes and Needs) Study. Pract Diab Int 2002;19:22-24a
-
(2002)
Pract Diab Int
, vol.19
-
-
Alberti, G.1
-
14
-
-
0036736185
-
When oral agents fail: Practical barriers to starting insulin
-
Korykowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes 2002;26(Suppl 3):S18-24
-
(2002)
Int J Obes
, vol.26
, Issue.SUPPL. 3
-
-
Korykowski, M.1
-
15
-
-
32144448938
-
Standards of medical care in diabetes - 2006
-
American Diabetes Association
-
American Diabetes Association: Standards of medical care in diabetes - 2006. Diabetes Care 2006;29:S4-42
-
(2006)
Diabetes Care
, vol.29
-
-
-
16
-
-
34250895451
-
Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus
-
DOI 10.1592/phco.27.7.948
-
Cobden D, Lee WC, Balu S, et al. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus. Pharmacotherapy 2007;27:948-962 (Pubitemid 46986681)
-
(2007)
Pharmacotherapy
, vol.27
, Issue.7
, pp. 948-962
-
-
Cobden, D.1
Lee, W.C.2
Balu, S.3
Joshi, A.V.4
Pashos, C.L.5
-
17
-
-
33751566656
-
Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: An analysis of third-party managed care claims data
-
DOI 10.1016/j.clinthera.2006.10.004, PII S014929180600244X
-
Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clinical Therapeutics 2006;28:1712-1725 (Pubitemid 44841979)
-
(2006)
Clinical Therapeutics
, vol.28
, Issue.10
, pp. 1712-1725
-
-
Lee, W.C.1
Balu, S.2
Cobden, D.3
Joshi, A.V.4
Pashos, C.L.5
-
18
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
19
-
-
0032511566
-
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)UK Prospective Diabetes Study (UKPDS) Group
-
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854-865
-
(1998)
Lancet
, vol.352
, pp. 854-865
-
-
-
20
-
-
15044342214
-
Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus
-
DOI 10.1016/j.coph.2004.11.005, PII S1471489205000147
-
Delorme S, Chiasson JL. Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus. Curr Opin Pharmacol 2005;5:184-189 (Pubitemid 40378751)
-
(2005)
Current Opinion in Pharmacology
, vol.5
, Issue.2 SPEC. ISS
, pp. 184-189
-
-
Delorme, S.1
Chiasson, J.-L.2
-
21
-
-
0036483958
-
Sulfonylurea Inadequacy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective diabetes Study (UKPDS 57)
-
Wright A, Burden AC, Paisey RB, et al. Sulfonylurea Inadequacy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective diabetes Study (UKPDS 57). Diabetes Care 2002;25(2):330-336
-
(2002)
Diabetes Care
, vol.25
, Issue.2
, pp. 330-336
-
-
Wright, A.1
Burden, A.C.2
Paisey, R.B.3
-
22
-
-
29944436303
-
-
IDF Clinical Guidelines Task Force. Brussels: International Diabetes Federation
-
IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. Brussels: International Diabetes Federation, 2005
-
(2005)
Global Guideline for Type 2 Diabetes
-
-
-
23
-
-
0012734054
-
-
Asia-Pacific Type 2 diabetes Policy Group. Health Communications Australia Pty Limited and In Vivo Communication Pty Limited, Sydney, Australia
-
Type 2 diabetes practical targets and treatments, 3rd edn. Asia-Pacific Type 2 diabetes Policy Group. Health Communications Australia Pty Limited and In Vivo Communication Pty Limited, Sydney, Australia, 2002
-
(2002)
Type 2 Diabetes Practical Targets and Treatments, 3rd Edn.
-
-
-
24
-
-
1042302783
-
Standards of medical care in diabetes
-
American Diabetes Association
-
American Diabetes AssociationStandards of medical care in diabetes. Diabetes Care 2004;27:S15-35
-
(2004)
Diabetes Care
, vol.27
-
-
-
25
-
-
0032887833
-
A desktop guide to Type 2 diabetes mellitus
-
DOI 10.1046/j.1464-5491.1999.00166.x
-
European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diabet Med 1999;16:716-730 (Pubitemid 29459269)
-
(1999)
Diabetic Medicine
, vol.16
, Issue.9
, pp. 716-730
-
-
Aguilar, M.1
Alberti, K.G.M.M.2
Amiel, S.A.3
Azzopardi, J.4
Berne, C.5
Bilous, R.W.6
Borch-Johnsen, K.7
Cathelineau, G.8
Cromme, P.V.M.9
Dawson, A.10
Elphick, R.11
Ericsson, A.12
Hadden, D.R.13
Heine, R.J.14
Home, P.D.15
Kalo, I.16
Kangas, T.17
Landgraf, R.18
Lauritzen, T.19
Massi-Benedetti, M.20
Mitrakou-Fanariotou, A.21
Pieber, T.22
Pruijs- Brands, A.23
Schatz, H.24
Scherbaum, W.25
Serhiyenko, A.26
Sieradzki, J.27
Swift, P.28
Uccioli, L.29
Van Crombrugge, P.30
Wientjens, W.H.J.M.31
Yilmaz, M.T.32
Yki-Jarvinen, H.33
more..
-
26
-
-
0036650074
-
The Oxford International Diabetes Summit: Implications of the DAWN study
-
The Oxford International Diabetes Summit: Implications of the DAWN study. Pract Diab Int 2002;19:187-192
-
(2002)
Pract Diab Int
, vol.19
, pp. 187-192
-
-
|